Content about Diabetes mellitus

January 17, 2012

Danish drug maker Novo Nordisk is partnering with cooking show host Paula Deen to launch a campaign to help adults find ways to manage challenges associated with Type 2 diabetes, the company said Tuesday.

PRINCETON, N.J. — Danish drug maker Novo Nordisk is partnering with cooking show host Paula Deen to launch a campaign to help adults find ways to manage challenges associated with Type 2 diabetes, the company said Tuesday.

Deen and her sons, Bobby and Jamie, star in a series of videos as part of the Diabetes in a New Light initiative, in which Deen is sharing her personal diabetes story for the first time.

January 16, 2012

The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

January 12, 2012

Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system.

MANNHEIM, Germany — Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system. The meter is smaller than a standard credit card, employs a large backlit display and does not require any manual coding or code key for enhanced ease of use, the company stated. It also offers improved functions such as customizable test reminders, pre- and postmeal markers and average glucose calculation.

January 11, 2012

A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

SAN DIEGO — A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

January 10, 2012

CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

WASHINGTON — CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

January 10, 2012

Winn-Dixie on Tuesday joined the Diabetes Prevention and Control Alliance, an initiative aimed at tipping the scales against the epidemic of diabetes, prediabetes and obesity by expanding access to community-based programs that use evidence-based approaches to help prevent and control diabetes.

ORLANDO, Fla. — Winn-Dixie on Tuesday joined the Diabetes Prevention and Control Alliance, an initiative aimed at tipping the scales against the epidemic of diabetes, prediabetes and obesity by expanding access to community-based programs that use evidence-based approaches to help prevent and control diabetes.

January 9, 2012

A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

WOONSOCKET, R.I. — A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

January 9, 2012

Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

PITTSBURGH — Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

Mylan said that it was sued by Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs in the U.S. District Court for the Southern District of New York in response to Mylan's filing a regulatory approval application with the Food and Drug Administration for a generic version of Actoplus Met XR (pioglitazone hydrochloride and metformin hydrochloride) extended-release tablets in the 15-mg/1,000-mg and 30-mg/1,000-mg strengths.

January 9, 2012

Drug maker Perrigo is buying a privately owned distributor of diabetes products, the company said Monday.

ALLEGAN, Mich. — Drug maker Perrigo is buying a privately owned distributor of diabetes products, the company said Monday.

Perrigo announced the $36 million acquisition of Alpharetta, Ga.-based CanAm Care, whose assets include Dex4 hypoglycemia products, insulin delivery syringes and pen needles, lancing, wound care and compression stockings.

January 9, 2012

Many patients that are at risk of Type 2 diabetes don't believe they require lifestyle counseling to help them curb their chance of developing the disease, according to new research published in the journal Diabetes Care.

ALEXANDRIA, Va. — Many patients that are at risk of Type 2 diabetes don't believe they require lifestyle counseling to help them curb their chance of developing the disease, according to new research published in the journal Diabetes Care.

January 5, 2012

Medtronic has launched a blood-glucose monitor that allows remote monitoring of blood-glucose levels, the company said.

MINNEAPOLIS — Medtronic has launched a blood-glucose monitor that allows remote monitoring of blood-glucose levels, the company said.

The Minneapolis-based device maker announced the Food and Drug Administration approval and launch of the mySentry remote glucose monitor, which allows a parent or caregiver to monitor a patient's blood-sugar levels from another room by communicating with the MiniMed Paradigm Real-Time Revel glucose-monitoring system.

January 5, 2012

A joint program of the National Institutes of Health and the Centers for Disease Control and Prevention has a new chairman.

WASHINGTON — A joint program of the National Institutes of Health and the Centers for Disease Control and Prevention has a new chairman.

John Buse of the University of North Carolina at Chapel Hill School of Medicine was appointed chair of the National Diabetes Education Program for a two-year term on Jan. 1. Buse succeeds Martha Funnell, who is a researcher at the University of Michigan Medical School, Ann Arbor, as well as co-director of the Behavioral, Clinical, and Health Systems Intervention Research Core at the Michigan Diabetes Research and Training Center.

January 4, 2012

A new study published in the recent issue of Sleep has found that young Type 1 diabetics may have difficulty controlling their blood-sugar levels due to lack of sleep.

DARIEN, Ill. — A new study published in the recent issue of Sleep has found that young Type 1 diabetics may have difficulty controlling their blood-sugar levels due to lack of sleep.

January 3, 2012

The market for meal replacement ready-to-drink shakes is expanding beyond the need for a shake-shake-sensible-meal diet plan, or the need for a protein booster, with a number of niche marketing opportunities.


The market for meal replacement ready-to-drink shakes is expanding beyond the need for a shake-shake-sensible-meal diet plan, or the need for a protein booster, with a number of niche marketing opportunities.


January 3, 2012

The role of the pharmacist has evolved considerably over the past decade, and few things exemplify that evolution more than pharmacists taking an active role in patients’ medication therapies and consulting with them one-on-one.


The role of the pharmacist has evolved considerably over the past decade, and few things exemplify that evolution more than pharmacists taking an active role in patients’ medication therapies and consulting with them one-on-one.


January 3, 2012

Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.

NEW YORK — Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.

December 22, 2011

Larry Hausner, the CEO of the American Diabetes Association, will serve as the 2012 chairman of the National Health Council's board of directors, NHC said.

WASHINGTON — Larry Hausner, the CEO of the American Diabetes Association, will serve as the 2012 chairman of the National Health Council's board of directors, NHC said.

December 21, 2011

Researchers at the University of Massachusetts Medical School said a diabetes prevention program they created was able to reduce prediabetes indicators among Latinos who were at risk of developing the disease.

WORCESTER, Mass. — Researchers at the University of Massachusetts Medical School said a diabetes prevention program they created was able to reduce prediabetes indicators among Latinos who were at risk of developing the disease.

December 21, 2011

An interdisciplinary research team at Worcester Polytechnic Institute is slated to develop a smartphone application that will help patients with advanced diabetes and foot ulcers.

WORCESTER, Mass. — An interdisciplinary research team at Worcester Polytechnic Institute is slated to develop a smartphone application that will help patients with advanced diabetes and foot ulcers.

December 20, 2011

Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

NEW YORK — Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

Type 1 diabetes is an autoimmune disorder in which the immune system attacks the pancreas's beta cells, but the drug, DiaPep277, stops that from happening, according to Bloomberg.

December 15, 2011

The American Diabetes Association on Thursday announced that Walgreens will become a national strategic partner, and that the national drug store chain again is working with the association as one of its partner charities within "Walgreens Way to Well Commitment" — a four-year, $100 million health-and-wellness initiative.

ALEXANDRIA, Va. — The American Diabetes Association on Thursday announced that Walgreens will become a national strategic partner, and that the national drug store chain again is working with the association as one of its partner charities within "Walgreens Way to Well Commitment" — a four-year, $100 million health-and-wellness initiative.

December 15, 2011

Short bursts of exercise appear to lower blood sugar in people with Type 2 diabetes, Canadian researchers have found.

HAMILTON, Ontario — Short bursts of exercise appear to lower blood sugar in people with Type 2 diabetes, researchers at Canada's McMaster University have found.

December 15, 2011

New research on a rare genetic disorder in which the pancreas fails to grow could shed light on how the organ develops and lead to treatments for Type 1 diabetes.

LONDON — New research on a rare genetic disorder in which the pancreas fails to grow could shed light on how the organ develops and lead to treatments for Type 1 diabetes.

In a study published in the journal Nature Genetics, an international team of researchers led by scientists at England's University of Exeter discovered a genetic mutation present in 15-in-27 people with a condition called pancreatic agenesis, finding a key role for the gene, GATA6, in the development of pacreatic cells.

December 15, 2011

A study conducted by Bristol-Myers Squibb and AstraZeneca found that adding an investigational compound to an existing Type 2 diabetes treatment may help reduce blood-glucose levels among patients.

DUBAI — A study conducted by Bristol-Myers Squibb and AstraZeneca found that adding an investigational compound to an existing Type 2 diabetes treatment may help reduce blood-glucose levels among patients.

December 8, 2011

A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

INDIANAPOLIS — A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

Eli Lilly & Co. and Boehringer Ingelheim announced results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, presenting results at the International Diabetes Federation World Diabetes Conference in Dubai.